In addition, patients with metabolic syndrome reveal a higher percentage of circulating CXCR6 expressing platelets and CXCR6 expressing platelet-bound neutrophils, resulting in enhanced CXCR6/CXCL16-dependent adhesion to the dysfunctional arterial endothelium (57). Here, CXCL16 is linked to metabolic syndrome.